Delivery Order SPE2DB25D3022-SPE2DB25FWAWD

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,116.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone prop HFA 110 mcg 12gm, a pharmaceutical product, with a completion date of January 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,553.70 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.12 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,410.26, is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a Period of Performance ending on May 2, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $1,214.58, is for the delivery of 4564898560 units of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The award is a Delivery Order contract with a Firm Fixed Price pricing type. This contract is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,525.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm, a pharmaceutical product, with an ultimate completion date of December 17, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $3,776.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a medical product, and has a period of performance through March 31, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,642.91 firm fixed-price contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a performance period through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award, valued at $1,147.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568245444 FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC...
This federal contract award, valued at $1,780.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the procurement of 4567692331 - FLUTICASONE PROP HFA 44 MCG 10.6GM, a...
  • SPE2DB25D3022
    Indefinite Delivery Contract
  • SPE2DB25D3022-SPE2DB25FWAWD
    Delivery Order

This federal contract award, valued at $1,031.10, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a period of performance through March 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:45 AM